$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Comparison of the efficacy of domestic and imported versions of lenvatinib/lenvatinib
2026-02-01 22:25:32
Check Details
Which company develops and produces Belumosudil tablets and what is its background?
2026-02-01 22:25:32
Check Details
Analysis of the therapeutic effect and clinical application of Brivaracetam
2026-02-01 22:25:32
Check Details
What are the side effects of fezolinetant?
2026-02-01 22:25:32
Check Details
Can obeticholic acid reverse cirrhosis?
2026-02-01 22:25:32
Check Details
What will happen to your body after taking neratinib/neratinib (He Li'an) for one year?
2026-02-01 22:25:32
Check Details
FDA approves new CDx pembrolizumab/lenvatinib for endometrial cancer
2026-02-01 22:25:32
Check Details
What are the specific reimbursement conditions for Belumosudil tablets and how to apply?
2026-02-01 22:25:32
Check Details
What is the price of Brivaracetam in 2026? Market reference
2026-02-01 22:25:32
Check Details
What disease does fezolinetant treat?
2026-02-01 22:25:32
Check Details
What are the precautions when using obeticholic acid?
2026-02-01 22:25:32
Check Details
2026 Reimbursement Policy for Neratinib/Neratinib
2026-02-01 22:25:32
Check Details
1
2
...
2383
2384
2385
2386
2387
2388
2389
...
10229
10230
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
2
FDA Approves Zanidatamab (Ziihera): HER2 Bispecific Antibody Plus Immunotherapy for First-Line Gastric Cancer
3
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
4
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
5
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
6
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
7
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
8
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
9
Pretomanid Combination Therapy Safety Guide: BPaL Regimen Adverse Reaction Recognition and Monitoring
10
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
11
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring
12
Belzutifan (WELIREG) Treatment Guide: Duration, Onset of Action, and Monitoring Protocol